Is the FDA “doubling down” on a failed strategy?
"We’re using a poor man’s immune correlates of protection"
Last Thursday, the FDA convened its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss the future of covid vaccines.
The panel voted 21 to 0 in favor of moving towards a more simplified vaccine schedule - an annual shot which would be updated as new variants emerge - much like the annual flu shot.
Despi…